Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Current Drug Targets. Infectious Disorders|June 8, 2004
Candida and candidiasis: the cell wall as a potential molecular target for antifungal therapyDaniel Gozalbo, Patricia Roig, Eva Villamón, et al.
Infection and Immunity|January 24, 2006
Killed Candida albicans yeasts and hyphae inhibit gamma interferon release by murine natural killer cellsCelia Murciano, Eva Villamón, José-Enrique O'Connor, et al.
Expert Opinion on Medical Diagnostics|March 14, 2013
New prognostic markers in neuroblastomaSamuel Navarro, Marta Piqueras, Eva Villamón, et al.
Journal of Medical Microbiology|November 17, 2006
Impaired immune response to Candida albicans in aged miceCelia Murciano, Eva Villamón, Alberto Yáñez, et al.
Microbes and Infection|January 24, 2004
Toll-like receptor-2 is essential in murine defenses against Candida albicans infectionsEva Villamón, Daniel Gozalbo, Patricia Roig, et al.
Cancer Cell International|February 10, 2018
Imiquimod inhibits growth and induces differentiation of myeloid leukemia cell linesEva Villamón, Javier González-Fernández, Esperanza Such, et al.
Antonie Van Leeuwenhoek|August 9, 2003
Glyceraldehyde-3-phosphate dehydrogenase, a glycolytic enzyme present in the periplasm of Aeromonas hydrophilaEva Villamón, Victor Villalba, M Mercedes Nogueras, et al.
Virchows Archiv : an International Journal of Pathology|June 25, 2008
Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastomaEva Villamón, Marta Piqueras, Carlos Mackintosh, et al.
Pageof 4